{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:27:22Z","timestamp":1793878042878,"version":"4.7.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04224-x","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T14:39:42Z","timestamp":1755527982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Meprin \u03b2 activity modulates cellular proliferation via trans-signaling IL-6-mediated AKT\/ERK pathway in IR-induced kidney injury"],"prefix":"10.1186","volume":"26","author":[{"given":"Shaymaa","family":"Abousaad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faihaa","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Abouzeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Adhiambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elimelda Moige","family":"Ongeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"1","key":"4224_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jhep.2022.02.009","volume":"77","author":"KR Patidar","year":"2022","unstructured":"Patidar KR, Naved MA, Grama A, et al. Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury. J Hepatol. 2022;77(1):108\u201315. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.009","journal-title":"J Hepatol"},{"issue":"6","key":"4224_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/14656566.2022.2050214","volume":"23","author":"Y Xu","year":"2022","unstructured":"Xu Y, Zou P, Cao X. Advances in pharmacotherapy for acute kidney injury. Expert Opin Pharmacother. 2022;23(6):713\u201326. https:\/\/doi.org\/10.1080\/14656566.2022.2050214","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"4224_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.kint.2020.01.036","volume":"98","author":"SJ Han","year":"2020","unstructured":"Han SJ, Williams RM, D\u2019Agati V, Jaimes EA, Heller DA, Lee HT. Selective nanoparticle-mediated targeting of renal tubular toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney Int. 2020;98(1):76\u201387. https:\/\/doi.org\/10.1016\/j.kint.2020.01.036","journal-title":"Kidney Int"},{"issue":"2","key":"4224_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/ijms22020816","volume":"22","author":"C V\u00e1zquez-Carballo","year":"2021","unstructured":"V\u00e1zquez-Carballo C, Guerrero-Hue M, Garc\u00eda-Caballero C, et al. Toll-Like receptors in acute kidney injury. Int J Mol Sci. 2021;22(2):816. https:\/\/doi.org\/10.3390\/ijms22020816","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4224_CR5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1523-1755.2004.761_2.x","volume":"66","author":"JV Bonventre","year":"2004","unstructured":"Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 2004;66(2):480\u201385. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.761_2.x","journal-title":"Kidney Int"},{"issue":"2","key":"4224_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1523-1755.2004.761_3.x","volume":"66","author":"JJ Friedewald","year":"2004","unstructured":"Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004;66(2):486\u201391. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.761_3.x","journal-title":"Kidney Int"},{"issue":"1","key":"4224_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1556\/2060.2020.00003","volume":"107","author":"X Meng","year":"2020","unstructured":"Meng X, Wei M, Wang D, et al. The protective effect of hesperidin against renal ischemia-reperfusion injury involves the TLR-4\/NF-\u03baB\/iNOS pathway in rats. Physiol Int. 2020;107(1):82\u201391. https:\/\/doi.org\/10.1556\/2060.2020.00003","journal-title":"Physiol Int"},{"issue":"3","key":"4224_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1152\/physiol.00046.2014","volume":"30","author":"Q Cao","year":"2015","unstructured":"Cao Q, Harris DCH, Wang Y. Macrophages in Kidney Injury, Inflammation, and Fibrosis. Physiology. 2015;30(3):183\u201394. https:\/\/doi.org\/10.1152\/physiol.00046.2014","journal-title":"Physiology"},{"issue":"5","key":"4224_CR9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta BBA - Mol Cell Res. 2011;1813(5):878\u201388. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","journal-title":"Biochim Biophys Acta BBA - Mol Cell Res"},{"issue":"1","key":"4224_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cyto.2014.05.024","volume":"70","author":"J Wolf","year":"2014","unstructured":"Wolf J, Rose-John S, Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine. 2014;70(1):11\u201320. https:\/\/doi.org\/10.1016\/j.cyto.2014.05.024","journal-title":"Cytokine"},{"issue":"5","key":"4224_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.mam.2008.08.002","volume":"29","author":"E Sterchi","year":"2008","unstructured":"Sterchi E, Stocker W, Bond J. Meprins, membrane-bound and secreted astacin metalloproteinases. Mol Aspects Med. 2008;29(5):309\u201328. https:\/\/doi.org\/10.1016\/j.mam.2008.08.002","journal-title":"Mol Aspects Med"},{"issue":"11","key":"4224_CR12","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.bbamcr.2017.05.011","volume":"1864","author":"P Arnold","year":"2017","unstructured":"Arnold P, Otte A, Becker-Pauly C. Meprin metalloproteases: Molecular regulation and function in inflammation and fibrosis. Biochim Biophys Acta BBA - Mol Cell Res. 2017;1864(11):2096\u2013104. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.05.011","journal-title":"Biochim Biophys Acta BBA - Mol Cell Res"},{"issue":"5","key":"4224_CR13","doi-asserted-by":"publisher","first-page":"115327","DOI":"10.1016\/j.bmc.2020.115327","volume":"28","author":"S Kaur","year":"2020","unstructured":"Kaur S, Bansal Y, Kumar R, Bansal G. A panoramic review of IL-6: structure, pathophysiological roles and inhibitors. Bioorg Med Chem. 2020;28(5):115327. https:\/\/doi.org\/10.1016\/j.bmc.2020.115327","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"4224_CR14","doi-asserted-by":"publisher","first-page":"7580","DOI":"10.1074\/jbc.M113.546309","volume":"289","author":"TR Keiffer","year":"2014","unstructured":"Keiffer TR, Bond JS. Meprin metalloproteases inactivate interleukin 6. J Biol Chem. 2014;289(11):7580\u201388. https:\/\/doi.org\/10.1074\/jbc.M113.546309","journal-title":"J Biol Chem"},{"issue":"2","key":"4224_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/PL00012162","volume":"4","author":"H Osawa","year":"2000","unstructured":"Osawa H, Yamabe H, Kaizuka M, et al. Interleukin 6 as a marker of mesangial cell proliferative activity. Clin Exp Nephrol. 2000;4(2):119\u201325. https:\/\/doi.org\/10.1007\/PL00012162","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"4224_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1677\/ERC-09-0200","volume":"17","author":"FR Santer","year":"2010","unstructured":"Santer FR, Malinowska K, Culig Z, Cavarretta IT. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells. Endocr Relat Cancer. 2010;17(1):241\u201353. https:\/\/doi.org\/10.1677\/ERC-09-0200","journal-title":"Endocr Relat Cancer"},{"key":"4224_CR17","doi-asserted-by":"publisher","unstructured":"Wu Z, Yang W, Liu J, Zhang F. Interleukin-6 upregulates SOX18 expression in osteosarcoma. OncoTargets Ther. 2017;10:5329\u201336. https:\/\/doi.org\/10.2147\/OTT.S149905","DOI":"10.2147\/OTT.S149905"},{"issue":"4","key":"4224_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cpt.782","volume":"102","author":"S Rose-John","year":"2017","unstructured":"Rose-John S. The soluble interleukin 6 receptor: advanced therapeutic options in inflammation. Clin Pharmacol Ther. 2017;102(4):591\u201398. https:\/\/doi.org\/10.1002\/cpt.782","journal-title":"Clin Pharmacol Ther"},{"key":"4224_CR19","doi-asserted-by":"publisher","unstructured":"Jorcyk C, Tawara K, Jorcyk C. Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res. Published online May 2011:177. https:\/\/doi.org\/10.2147\/CMAR.S18101","DOI":"10.2147\/CMAR.S18101"},{"key":"4224_CR20","doi-asserted-by":"publisher","unstructured":"Abousaad S, Ahmed F, Abouzeid A, Ongeri EM. Meprin \u03b2 expression modulates the interleukin-6 mediated JAK2-STAT3 signaling pathway in ischemia\/reperfusion-induced kidney injury. Physiol Rep. 2022;10(18). https:\/\/doi.org\/10.14814\/phy2.15468","DOI":"10.14814\/phy2.15468"},{"issue":"3","key":"4224_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1172\/JCI119568","volume":"100","author":"D Bokemeyer","year":"1997","unstructured":"Bokemeyer D, Guglielmi KE, McGinty A, Sorokin A, Lianos EA, Dunn MJ. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest. 1997;100(3):582\u201388. https:\/\/doi.org\/10.1172\/JCI119568","journal-title":"J Clin Invest"},{"issue":"5","key":"4224_CR22","first-page":"2212","volume":"159","author":"A Ogata","year":"1997","unstructured":"Ogata A, Chauhan D, Teoh G, et al. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. J Immunol Baltim Md 1950. 1997;159(5):2212\u201321","journal-title":"J Immunol Baltim Md 1950"},{"issue":"10","key":"4224_CR23","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1172\/JCI126091","volume":"129","author":"DC Fajgenbaum","year":"2019","unstructured":"Fajgenbaum DC, Langan RA, Japp AS, et al. Identifying and targeting pathogenic PI3K\/AKT\/mTOR signaling in IL-6 blockade\u2013refractory idiopathic multicentric Castleman disease. J Clin Invest. 2019;129(10):4451\u201363. https:\/\/doi.org\/10.1172\/JCI126091","journal-title":"J Clin Invest"},{"issue":"1","key":"4224_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12989-018-0240-x","volume":"15","author":"CW Liu","year":"2018","unstructured":"Liu CW, Lee TL, Chen YC, et al. PM2.5-induced oxidative stress increases intercellular adhesion molecule-1 expression in lung epithelial cells through the IL-6\/AKT\/STAT3\/NF-\u03baB-dependent pathway. Part Fibre Toxicol. 2018;15(1):4. https:\/\/doi.org\/10.1186\/s12989-018-0240-x","journal-title":"Part Fibre Toxicol"},{"issue":"1","key":"4224_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","volume":"16","author":"MM Zegeye","year":"2018","unstructured":"Zegeye MM, Lindkvist M, F\u00e4lker K, et al. Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Commun Signal. 2018;16(1):55. https:\/\/doi.org\/10.1186\/s12964-018-0268-4","journal-title":"Cell Commun Signal"},{"issue":"4","key":"4224_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/carcin\/bgv017","volume":"36","author":"H Liu","year":"2015","unstructured":"Liu H, Ren G, Wang T, et al. Aberrantly expressed Fra-1 by IL-6\/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial\u2013mesenchymal transition. Carcinogenesis. 2015;36(4):459\u201368. https:\/\/doi.org\/10.1093\/carcin\/bgv017","journal-title":"Carcinogenesis"},{"issue":"1","key":"4224_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1078-0432.CCR-10-1198","volume":"17","author":"I Tawara","year":"2011","unstructured":"Tawara I, Koyama M, Liu C, et al. Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res. 2011;17(1):77\u201388. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1198","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4224_CR28","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/ijc.23261","volume":"122","author":"B Wegiel","year":"2008","unstructured":"Wegiel B, Bjartell A, Culig Z, Persson JL. Interleukin-6 activates PI3K\/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer. 2008;122(7):1521\u201329. https:\/\/doi.org\/10.1002\/ijc.23261","journal-title":"Int J Cancer"},{"issue":"4","key":"4224_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1128\/MCB.23.4.1221-1230.2003","volume":"23","author":"LP Norman","year":"2003","unstructured":"Norman LP, Jiang W, Han X, Saunders TL, Bond JS. Targeted disruption of the meprin \u03b2 gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles. Mol Cell Biol. 2003;23(4):1221\u201330. https:\/\/doi.org\/10.1128\/MCB.23.4.1221-1230.2003","journal-title":"Mol Cell Biol"},{"issue":"10","key":"4224_CR30","doi-asserted-by":"publisher","first-page":"F1026","DOI":"10.1152\/ajprenal.00562.2015","volume":"310","author":"N Kumar","year":"2016","unstructured":"Kumar N, Nakagawa P, Janic B, et al. The anti-inflammatory peptide Ac-SDKP is released from thymosin-\u03b24 by renal meprin-\u03b1 and prolyl oligopeptidase. Am J Physiol-Ren Physiol. 2016;310(10):F1026\u2013F1034. https:\/\/doi.org\/10.1152\/ajprenal.00562.2015","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"3","key":"4224_CR31","doi-asserted-by":"publisher","first-page":"F480","DOI":"10.1152\/ajprenal.00214.2007","volume":"294","author":"J Bylander","year":"2008","unstructured":"Bylander J, Li Q, Ramesh G, Zhang B, Reeves WB, Bond JS. Targeted disruption of the meprin metalloproteinase \u03b2 gene protects against renal ischemia-reperfusion injury in mice. Am J Physiol-Ren Physiol. 2008;294(3):F480\u2013F490. https:\/\/doi.org\/10.1152\/ajprenal.00214.2007","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"1","key":"4224_CR32","doi-asserted-by":"publisher","first-page":"F56","DOI":"10.1152\/ajprenal.00167.2014","volume":"308","author":"JMV Niyitegeka","year":"2015","unstructured":"Niyitegeka JMV, Bastidas AC, Newman RH, Taylor SS, Ongeri EM. Isoform-specific interactions between meprin metalloproteases and the catalytic subunit of protein kinase A: significance in acute and chronic kidney injury. Am J Physiol-Ren Physiol. 2015;308(1):F56\u2013F68. https:\/\/doi.org\/10.1152\/ajprenal.00167.2014","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"4","key":"4224_CR33","doi-asserted-by":"publisher","first-page":"101678","DOI":"10.1016\/j.xpro.2022.101678","volume":"3","author":"YT Cheng","year":"2022","unstructured":"Cheng YT, Tu YC, Chou YH, Lai CF. Protocol for renal ischemia-reperfusion injury by flank incisions in mice. STAR Protoc. 2022;3(4):101678. https:\/\/doi.org\/10.1016\/j.xpro.2022.101678","journal-title":"STAR Protoc"},{"issue":"4","key":"4224_CR34","doi-asserted-by":"publisher","first-page":"F1068","DOI":"10.1152\/ajprenal.00305.2019","volume":"317","author":"L Scarfe","year":"2019","unstructured":"Scarfe L, Menshikh A, Newton E, et al. Long-term outcomes in mouse models of ischemia-reperfusion-induced acute kidney injury. Am J Physiol-Ren Physiol. 2019;317(4):F1068\u2013F1080. https:\/\/doi.org\/10.1152\/ajprenal.00305.2019","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"6","key":"4224_CR35","first-page":"628","volume":"50","author":"J Deng","year":"2000","unstructured":"Deng J, Clair MS, Everett C, Reitman M, Star RA. Buprenorphine given after surgery does not alter renal ischemia\/reperfusion injury. Comp Med. 2000;50(6):628\u201332","journal-title":"Comp Med"},{"issue":"2","key":"4224_CR36","first-page":"105","volume":"63","author":"KR Jacobsen","year":"2013","unstructured":"Jacobsen KR, Fauerby N, Raida Z, et al. Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL\/6 male mice. Comp Med. 2013;63(2):105\u201313","journal-title":"Comp Med"},{"issue":"5","key":"4224_CR37","first-page":"641","volume":"24","author":"O Kalliokoski","year":"2010","unstructured":"Kalliokoski O, Abelson KS, Koch J, et al. The effect of voluntarily ingested buprenorphine on rats subjected to surgically induced global cerebral ischaemia. Vivo. 2010;24(5):641\u201346","journal-title":"Vivo"},{"issue":"3","key":"4224_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1176\/jnp.2007.19.3.331","volume":"19","author":"B Yulug","year":"2007","unstructured":"Yulug B, Cam E, Yildiz A, Kilic E. Buprenorphine does not aggrevate ischemic neuronal injury in experimental focal cerebral ischemia. J Neuropsychiatry Clin Neurosci. 2007;19(3):331\u201334. https:\/\/doi.org\/10.1176\/jnp.2007.19.3.331","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"4224_CR39","doi-asserted-by":"publisher","first-page":"F1147","DOI":"10.1152\/ajprenal.00571.2019","volume":"318","author":"F Ahmed","year":"2020","unstructured":"Ahmed F, Mwiza JM, Fernander M, Yahaya I, Abousaad S, Ongeri EM. Meprin-\u03b2 activity modulates the \u03b2-catalytic subunit of protein kinase A in ischemia-reperfusion-induced acute kidney injury. Am J Physiol-Ren Physiol. 2020;318(5):F1147\u2013F1159. https:\/\/doi.org\/10.1152\/ajprenal.00571.2019","journal-title":"Am J Physiol-Ren Physiol"},{"key":"4224_CR40","doi-asserted-by":"publisher","first-page":"2489842","DOI":"10.1155\/2017\/2489842","volume-title":"Evid Based Complement Alternat Med","author":"M Chen","year":"2017","unstructured":"Chen M, Ding P, Yang L, et al. Evaluation of anti-inflammatory activities of qingre-qushi recipe (qrqs) against atopic dermatitis: potential mechanism of inhibition of il-33\/st2 signal transduction. Ren K editor. Evid Based Complement Alternat Med. 2017;2017(1):2489842. https:\/\/doi.org\/10.1155\/2017\/2489842"},{"issue":"4","key":"4224_CR41","doi-asserted-by":"publisher","first-page":"F871","DOI":"10.1152\/ajprenal.00703.2010","volume":"301","author":"EM Ongeri","year":"2011","unstructured":"Ongeri EM, Anyanwu O, Reeves WB, Bond JS. Villin and actin in the mouse kidney brush-border membrane bind to and are degraded by meprins, an interaction that contributes to injury in ischemia-reperfusion. Am J Physiol-Ren Physiol. 2011;301(4):F871\u2013F882. https:\/\/doi.org\/10.1152\/ajprenal.00703.2010","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"9","key":"4224_CR42","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1681\/ASN.2011111072","volume":"23","author":"Q Peng","year":"2012","unstructured":"Peng Q, Li K, Smyth LA, et al. C3a and C5a Promote Renal Ischemia-Reperfusion Injury. J Am Soc Nephrol. 2012;23(9):1474\u201385. https:\/\/doi.org\/10.1681\/ASN.2011111072","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"4224_CR43","doi-asserted-by":"publisher","first-page":"F1099","DOI":"10.1152\/ajprenal.00649.2012","volume":"304","author":"R Sohotnik","year":"2013","unstructured":"Sohotnik R, Nativ O, Abbasi A, et al. Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol-Ren Physiol. 2013;304(8):F1099\u2013F1104. https:\/\/doi.org\/10.1152\/ajprenal.00649.2012","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"1","key":"4224_CR44","doi-asserted-by":"publisher","first-page":"40984","DOI":"10.1038\/srep40984","volume":"7","author":"BG Jung","year":"2017","unstructured":"Jung BG, Wang X, Yi N, Ma J, Turner J, Samten B. Early secreted antigenic target of 6-kda of mycobacterium tuberculosis stimulates il-6 production by macrophages through activation of STAT3. Sci Rep. 2017;7(1):40984. https:\/\/doi.org\/10.1038\/srep40984","journal-title":"Sci Rep"},{"issue":"2","key":"4224_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41423-020-0420-0","volume":"18","author":"X Wang","year":"2021","unstructured":"Wang X, Xiang Z, Tsao GSW, Tu W. Exosomes derived from nasopharyngeal carcinoma cells induce IL-6 production from macrophages to promote tumorigenesis. Cell Mol Immunol. 2021;18(2):501\u201303. https:\/\/doi.org\/10.1038\/s41423-020-0420-0","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"4224_CR46","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.kint.2016.12.014","volume":"91","author":"A Andres-Hernando","year":"2017","unstructured":"Andres-Hernando A, Okamura K, Bhargava R, et al. Circulating IL-6 upregulates IL-10 production in splenic CD4+ T cells and limits acute kidney injury\u2013induced lung inflammation. Kidney Int. 2017;91(5):1057\u201369. https:\/\/doi.org\/10.1016\/j.kint.2016.12.014","journal-title":"Kidney Int"},{"issue":"14","key":"4224_CR47","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.7150\/thno.32352","volume":"9","author":"W Chen","year":"2019","unstructured":"Chen W, Yuan H, Cao W, et al. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. Theranostics. 2019;9(14):3980\u201391. https:\/\/doi.org\/10.7150\/thno.32352","journal-title":"Theranostics"},{"key":"4224_CR48","doi-asserted-by":"publisher","unstructured":"Lemay S, Rabb H, Postler G, Singh AK. Transplantation. Published online March 2000:959\u201363. https:\/\/doi.org\/10.1097\/00007890-200003150-00049","DOI":"10.1097\/00007890-200003150-00049"},{"issue":"6","key":"4224_CR49","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1681\/ASN.2007070744","volume":"19","author":"Y Nechemia-Arbely","year":"2008","unstructured":"Nechemia-Arbely Y, Barkan D, Pizov G, et al. IL-6\/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol. 2008;19(6):1106\u201315. https:\/\/doi.org\/10.1681\/ASN.2007070744","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"4224_CR50","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.7150\/thno.72515","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Xiong M, Fan Y, et al. Mecp2 protects kidney from ischemia-reperfusion injury through transcriptional repressing IL-6\/STAT3 signaling. Theranostics. 2022;12(8):3896\u2013910. https:\/\/doi.org\/10.7150\/thno.72515","journal-title":"Theranostics"},{"issue":"12","key":"4224_CR51","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1097\/01.ASN.0000101180.96787.02","volume":"14","author":"J Yoshino","year":"2003","unstructured":"Yoshino J, Monkawa T, Tsuji M, Hayashi M, Saruta T. Leukemia inhibitory factor is involved in tubular regeneration after experimental acute renal failure. J Am Soc Nephrol. 2003;14(12):3090\u2013101. https:\/\/doi.org\/10.1097\/01.ASN.0000101180.96787.02","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4224_CR52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1385\/CRIAI:28:3:","volume":"28","author":"R Atreya","year":"2005","unstructured":"Atreya R, Neurath MF. Involvement of il-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28(3):187\u201396. https:\/\/doi.org\/10.1385\/CRIAI:28:3:","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"4224_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1042\/bj20031163","volume":"378","author":"MN Kruse","year":"2004","unstructured":"Kruse MN, Becker C, Lottaz D, et al. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem J. 2004;378(2):383\u201389. https:\/\/doi.org\/10.1042\/bj20031163","journal-title":"Biochem J"},{"key":"4224_CR54","doi-asserted-by":"publisher","unstructured":"Armbrust F, Bickenbach K, Koudelka T, Tholey A, Pietrzik C, Becker-Pauly C Phosphorylation of meprin \u03b2 controls its cell surface abundance and subsequently diminishes ectodomain shedding. FASEB J. 2021;35(7). https:\/\/doi.org\/10.1096\/fj.202100271R","DOI":"10.1096\/fj.202100271R"},{"key":"4224_CR55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"8","author":"H Su","year":"2017","unstructured":"Su H, Lei CT, Zhang C. Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol. 2017;8:405. https:\/\/doi.org\/10.3389\/fimmu.2017.00405","journal-title":"Front Immunol"},{"issue":"5","key":"4224_CR56","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0272-6386(03)00206-3","volume":"41","author":"O Kwon","year":"2003","unstructured":"Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained arf after ischemic injury in renal allografts. Am J Kidney Dis. 2003;41(5):1074\u201387. https:\/\/doi.org\/10.1016\/S0272-6386(03)00206-3","journal-title":"Am J Kidney Dis"},{"key":"4224_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4615-0685-0_19","volume-title":"Progress in Basic and Clinical Immunology. Vol 495. Advances in Experimental Medicine and Biology","author":"S Rose-John","year":"2001","unstructured":"Rose-John S. Coordination of interleukin-6 biology by membrane bound and soluble receptors. Mackiewicz A, Kurpisz M, \u017beromski J editors. Progress in Basic and Clinical Immunology. Vol 495. Advances in Experimental Medicine and Biology. Springer US; 2001:145\u201351. https:\/\/doi.org\/10.1007\/978-1-4615-0685-0_19"},{"issue":"Supplement_1","key":"4224_CR58","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2337\/db18-496-P","volume":"67","author":"HYH Lin","year":"2018","unstructured":"Lin HYH, Chen Y, Chen YH, Ta A, Lee H, Wang PH. Mechanistic role of mitochondrial akt1 in kidney injury and diabetic nephropathy. Diabetes. 2018;67(Supplement_1):496\u2013P. https:\/\/doi.org\/10.2337\/db18-496-P","journal-title":"Diabetes"},{"issue":"Supplement_1","key":"4224_CR59","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2337\/db19-515-P","volume":"68","author":"H You-Hsien Lin","year":"2019","unstructured":"You-Hsien Lin H, Chen YH, Ta A, Lee H, Chen Y, Wang PH. 515-P: mitochondrial akt1 in renal tubules is a novel modulator for the development of glomerulosclerosis and subsequent renal failure. Diabetes. 2019;68(Supplement_1):515\u2013P. https:\/\/doi.org\/10.2337\/db19-515-P","journal-title":"Diabetes"},{"issue":"6","key":"4224_CR60","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.juro.2009.08.085","volume":"182","author":"C Porta","year":"2009","unstructured":"Porta C, Figlin RA. Phosphatidylinositol-3-Kinase\/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-Kinase\/Akt Inhibitors. J Urol. 2009;182(6):2569\u201377. https:\/\/doi.org\/10.1016\/j.juro.2009.08.085","journal-title":"J Urol"},{"issue":"12","key":"4224_CR61","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.bbadis.2013.07.001","volume":"1832","author":"HS Jang","year":"2013","unstructured":"Jang HS, Han SJ, Kim JI, Lee S, Lipschutz JH, Park KM. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia\/reperfusion injury. Biochim Biophys Acta BBA - Mol Basis Dis. 2013;1832(12):1998\u20132008. https:\/\/doi.org\/10.1016\/j.bbadis.2013.07.001","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"issue":"18","key":"4224_CR62","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.3390\/ijms21186911","volume":"21","author":"HY Jung","year":"2020","unstructured":"Jung HY, Oh SH, Ahn JS, et al. NOX1 inhibition attenuates kidney ischemia-reperfusion injury via inhibition of ros-mediated erk signaling. Int J Mol Sci. 2020;21(18):6911. https:\/\/doi.org\/10.3390\/ijms21186911","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4224_CR63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332. https:\/\/doi.org\/10.1038\/s41580-020-0255-7","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"18","key":"4224_CR64","doi-asserted-by":"publisher","first-page":"dev199767","DOI":"10.1242\/dev.199767","volume":"148","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Goto Y, Kondo Y, Aoki K. Shedding light on developmental ERK signaling with genetically encoded biosensors. Development. 2021;148(18):dev199767. https:\/\/doi.org\/10.1242\/dev.199767","journal-title":"Development"},{"issue":"15","key":"4224_CR65","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1016\/j.febslet.2005.03.024","volume":"579","author":"M Baccarini","year":"2005","unstructured":"Baccarini M. Second nature: biological functions of the raf-1 \u201ckinase. FEBS Lett. 2005;579(15):3271\u201377. https:\/\/doi.org\/10.1016\/j.febslet.2005.03.024","journal-title":"FEBS Lett"},{"issue":"22","key":"4224_CR66","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","volume":"26","author":"S Meloche","year":"2007","unstructured":"Meloche S, Pouyss\u00e9gur J. The ERK1\/2 mitogen-activated protein kinase pathway as a master regulator of the\u2013 S-phase transition. Oncogene. 2007;26(22):3227\u201339. https:\/\/doi.org\/10.1038\/sj.onc.1210414","journal-title":"Oncogene"},{"issue":"2","key":"4224_CR67","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","volume":"68","author":"PP Roux","year":"2004","unstructured":"Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68(2):320\u201344. https:\/\/doi.org\/10.1128\/MMBR.68.2.320-344.2004","journal-title":"Microbiol Mol Biol Rev"},{"issue":"40","key":"4224_CR68","doi-asserted-by":"publisher","first-page":"42667","DOI":"10.18632\/oncotarget.5626","volume":"6","author":"D Malanga","year":"2015","unstructured":"Malanga D, De Marco C, Guerriero I, et al. The Akt1\/IL-6\/STAT3 pathway regulates growth of lung tumor initiating cells. Oncotarget. 2015;6(40):42667\u201386. https:\/\/doi.org\/10.18632\/oncotarget.5626","journal-title":"Oncotarget"},{"issue":"1","key":"4224_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2867-2-9","volume":"2","author":"L Song","year":"2002","unstructured":"Song L, Li Y, Shen B. Protein kinase ERK contributes to differential responsiveness of human myeloma cell lines to IFN\u03b1. Cancer Cell Int. 2002;2(1):9. https:\/\/doi.org\/10.1186\/1475-2867-2-9","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4224_CR70","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1530\/JME-15-0011","volume":"54","author":"Y Wang","year":"2015","unstructured":"Wang Y, Niu XL, Guo XQ, et al. IL6 induces TAM resistance via kinase-specific phosphorylation of ER\u03b1 in OVCA cells. J Mol Endocrinol. 2015;54(3):351\u201361. https:\/\/doi.org\/10.1530\/JME-15-0011","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"4224_CR71","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1172\/JCI117214","volume":"93","author":"R Witzgall","year":"1994","unstructured":"Witzgall R, Brown D, Schwarz C, Bonventre JV Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest. 1994;93(5):2175\u201388. https:\/\/doi.org\/10.1172\/JCI117214","journal-title":"J Clin Invest"},{"issue":"5","key":"4224_CR72","doi-asserted-by":"publisher","first-page":"C1203","DOI":"10.1152\/ajpcell.00432.2003","volume":"286","author":"K Zahedi","year":"2004","unstructured":"Zahedi K, Wang Z, Barone S, et al. Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure. Am J Physiol-Cell Physiol. 2004;286(5):C1203\u2013C1211. https:\/\/doi.org\/10.1152\/ajpcell.00432.2003","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"3","key":"4224_CR73","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/ki.1997.386","volume":"52","author":"SK Park","year":"1997","unstructured":"Park SK, Kang MJ, Kim W, Koh GY. Renal tubule regeneration after ischemic injury is coupled to the up-regulation and activation of cyclins and cyclin dependent kinases. Kidney Int. 1997;52(3):706\u201314. https:\/\/doi.org\/10.1038\/ki.1997.386","journal-title":"Kidney Int"},{"issue":"2","key":"4224_CR74","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/SHK.0000000000000586","volume":"46","author":"CC Wu","year":"2016","unstructured":"Wu CC, Chang CY, Chang ST, Chen SH 17\u03b2-estradiol accelerated renal tubule regeneration in male rats after ischemia\/reperfusion-induced acute kidney injury. Shock. 2016;46(2):158\u201363. https:\/\/doi.org\/10.1097\/SHK.0000000000000586","journal-title":"Shock"},{"issue":"7-12","key":"4224_CR75","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1699-0463.1992.tb04030.x","volume":"100","author":"P Malmstr\u00f6m","year":"1992","unstructured":"Malmstr\u00f6m P, Wester K, Vasko J, Busch C Expression of proliferative cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods. Apmis. 1992;100(7-12):988\u201392. https:\/\/doi.org\/10.1111\/j.1699-0463.1992.tb04030.x","journal-title":"Apmis"},{"issue":"7","key":"4224_CR76","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1681\/ASN.V17949","volume":"1","author":"JM Weinberg","year":"1991","unstructured":"Weinberg JM, Buchanan DN, Davis JA, Abarzua M Metabolic aspects of protection by glycine against hypoxic injury to isolated proximal tubules. J Am Soc Nephrol. 1991;1(7):949\u201358. https:\/\/doi.org\/10.1681\/ASN.V17949","journal-title":"J Am Soc Nephrol"}],"updated-by":[{"DOI":"10.1186\/s12882-025-04515-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000}}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04224-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T05:33:40Z","timestamp":1759469620000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4224"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04224-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5901359\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12882-025-04515-3","URL":"https:\/\/doi.org\/10.1186\/s12882-025-04515-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work in this study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at North Carolina A&T State University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}